Drop-Ship Kits Today – Our Current GI-MAP Turnaround Time: 7–10 Business Days

COVID-19 Update

 

COVID-19 Assay

As a high complexity laboratory specializing in molecular testing, we are in the position to offer hospitals and other healthcare institutions a COVID-19 Assay. Our LDT COVID-19 Assay launched on Friday, March 13, and it has been submitted to the FDA under the Emergency Use Authorization (EUA).

Our COVID-19 Assay was created to ease the burden on public health institutions, and is not available for ordering by clinicians at this time.

Read the Press Release announcing our COVID-19 Assay.

We are confident that this health crisis will soon pass, and things will return to normal. Until then, please remain vigilant in combating the spread of this disease, and take every precaution to ensure the health and safety of your families.

 

In Good Health,

 

Tony Hoffman - CEO

Tony Hoffman
Chief Executive Officer

 

David M. Brady - CMO

David M. Brady, ND, DC, CCN, DACBN, IFMCP, FACN
Chief Medical Officer


Contact Customer Service